Quick Answer
MADRIGAL PHARMACEUTICALS, INC. reported Total Assets of $1.26 billion for fiscal year 2025.
MADRIGAL PHARMACEUTICALS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.26B | +20.9% |
| 2024 | $1.04B | +62.7% |
| 2023 | $640.55M | +76.7% |
| 2022 | $362.57M | +32.6% |
| 2021 | $273.33M | -4.8% |
| 2020 | $287.00M | -35.1% |
| 2019 | $442.06M | -8.9% |
| 2018 | $485.43M | +152.4% |
| 2017 | $192.31M | +366.7% |
| 2016 | $41.21M | +11234.5% |
| 2015 | $363.6K | -99.6% |
| 2014 | $100.67M | +5.7% |
| 2013 | $95.20M | -7.6% |
| 2012 | $103.02M | +143.4% |
| 2011 | $42.32M | -21.7% |
| 2010 | $54.07M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.36B | +26.9% | +34.2% |
| June 30, 2025 | $1.02B | -7.7% | +1.9% |
| March 31, 2025 | $996.63M | -7.9% | -4.4% |
| December 31, 2024 | $1.04B | +62.7% | -2.9% |
| September 30, 2024 | $1.07B | +351.0% | -2.4% |
| June 30, 2024 | $1.10B | +263.6% | +1.6% |
| March 31, 2024 | $1.08B | +225.5% | +69.0% |
| December 31, 2023 | $640.55M | +76.7% | +169.2% |
- MADRIGAL PHARMACEUTICALS, INC. showed an increase of +20.9% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, MADRIGAL PHARMACEUTICALS, INC.’s total assets has grown by 2229.7% (from $54.07 million to $1.26 billion).
- The most recent figure is from MADRIGAL PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: